−460KRW
−31.33 BKRW
125.93 BKRW
45.28 M
About BUKWANG PHARM
Sector
Headquarters
Seoul
Employees (FY)
607
Website
Founded
1960
ISIN
KR7003000007
FIGI
BBG000BGY566
Bukwang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include gastrointestinal, central nervous system, metabolic drugs and others such as houlsehold suppiles and gift sets. The company was founded on October 17, 1960 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 003000 is 5990 KRW — it has decreased by 1.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BUKWANG PHARM stocks are traded under the ticker 003000.
BUKWANG PHARM is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
003000 stock is 3.19% volatile and has beta coefficient of 0.36. Check out the list of the most volatile stocks — is BUKWANG PHARM there?
BUKWANG PHARM revenue for the last quarter amounts to 35.90 B KRW despite the estimated figure of 39.10 B KRW. In the next quarter revenue is expected to reach 41.60 B KRW.
Yes, you can track BUKWANG PHARM financials in yearly and quarterly reports right on TradingView.
003000 stock has risen by 0.50% compared to the previous week, the month change is a 5.52% fall, over the last year BUKWANG PHARM has showed a 28.69% decrease.
003000 net income for the last quarter is −10.80 B KRW, while the quarter before that showed −16.11 B KRW of net income which accounts for 32.98% change. Track more BUKWANG PHARM financial stats to get the full picture.
Today BUKWANG PHARM has the market capitalization of 416.89 B, it has decreased by 6.66% over the last week.
Like other stocks, 003000 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BUKWANG PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 607.00 employees. See our rating of the largest employees — is BUKWANG PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BUKWANG PHARM technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BUKWANG PHARM stock shows the strong sell signal. See more of BUKWANG PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BUKWANG PHARM EBITDA is −33.20 B KRW, and current EBITDA margin is −26.37%. See more stats in BUKWANG PHARM financial statements.